Not applicableNot Yet RecruitingNCT04441008What this trial is testingAccelerated iTBS for Depression and SuicidalityWho this might be right forMajor Depressive DisorderSuicide University of Iowa 50
Testing effectiveness (Phase 2)Study completedNCT03439293What this trial is testingIxazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)Who this might be right forMultiple Myeloma Takeda 61
Not applicableWithdrawnNCT05943314What this trial is testingClinical Study on Safety and Efficacy of Anti-CLL1 /+CD33 CAR T Cells in the Treatment of Acute Myeloid LeukemiaWho this might be right forAcute Myeloid Leukemia Guangzhou Bio-gene Technology Co., Ltd
Testing effectiveness (Phase 2)WithdrawnNCT00845104What this trial is testingFludarabine Phosphate, Rituximab, and Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Relapsed or Not Responded To TreatmentWho this might be right forB-cell Chronic Lymphocytic LeukemiaRefractory Chronic Lymphocytic Leukemia Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Testing effectiveness (Phase 2)Study completedNCT02927964What this trial is testingTLR9 Agonist SD-101, Ibrutinib, and Radiation Therapy in Treating Patients With Relapsed or Refractory Grade 1-3A Follicular LymphomaWho this might be right forGrade 1 Follicular LymphomaGrade 2 Follicular LymphomaGrade 3a Follicular Lymphoma+4 more Robert Lowsky 21
Large-scale testing (Phase 3)Study completedNCT00117598What this trial is testingStudy Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL)Who this might be right forLymphoma Pfizer 169
Large-scale testing (Phase 3)Study completedNCT00309621What this trial is testingSafety and Efficacy of a Retinoid for the Treatment of Severe Chronic Hand DermatitisWho this might be right forHand Dermatoses Basilea Pharmaceutica 250
Testing effectiveness (Phase 2)Study completedNCT00076752What this trial is testingLymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus ErythematosusWho this might be right forLupus Erythematosus, Systemic National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT01253447What this trial is testingAKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)WithdrawnNCT02011126What this trial is testingImetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid TumorsWho this might be right forHepatoblastomaPreviously Treated Childhood RhabdomyosarcomaRecurrent Childhood Liver Cancer+5 more Children's Oncology Group
Early research (Phase 1)Study completedNCT00074243What this trial is testingCC-8490 in Treating Patients With Recurrent or Refractory High-Grade GliomasWho this might be right forBrain and Central Nervous System Tumors National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00027898What this trial is testingBortezomib and Combination Chemotherapy in Treating Patients With Advanced Solid TumorsWho this might be right forUnspecified Adult Solid Tumor, Protocol Specific National Cancer Institute (NCI) 27
Testing effectiveness (Phase 2)Looking for participantsNCT06191263What this trial is testingSafety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AMLWho this might be right forAcute Myeloid Leukemia Ryvu Therapeutics SA 98
Testing effectiveness (Phase 2)UnknownNCT05527821What this trial is testingStudy of Surufatinib Combined With Sintilimab and SCRT in Advanced Solid TumorsWho this might be right forUnresectable Advanced Solid TumorsBiliary Tract Tumors, Gastric Cancer, Small Cell Lung Cancer Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 36
Not applicableStudy completedNCT03363347What this trial is testingBRAF V600E and Redifferentiation Therapy in Radioiodine-refractory Papillary Thyroid CancerWho this might be right forThyroid Cancer Heidelberg University 25
Large-scale testing (Phase 3)Ended earlyNCT00109538What this trial is testingStudy of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)Who this might be right forMyelodysplastic SyndromesLeukemia, Myelomonocytic, ChronicMyelodysplasia+1 more Merck Sharp & Dohme LLC 47
Very early researchNot Yet RecruitingNCT06485648What this trial is testingMesenchymal Stem Cell Transfusion for the Treatment of Refractory Lupus NephritisWho this might be right forLupus Nephritis Chinese PLA General Hospital 96
Not applicableStudy completedNCT01963676What this trial is testingTranscranial Current Stimulation as a Treatment for Auditory Hallucinations in SchizophreniaWho this might be right forSchizophreniaSchizoaffective DisorderAuditory Hallucinations University of North Carolina, Chapel Hill 26
Early research (Phase 1)UnknownNCT03840317What this trial is testingSenl_1904A and Senl_1904B Chimeric Antigen Receptor （CAR） T-Cell in the Treatment of r/ r Acute B Lymphocytic LeukemiaWho this might be right forAcute Lymphocytic Leukemia Hebei Senlang Biotechnology Inc., Ltd. 20
Testing effectiveness (Phase 2)Study completedNCT01865617What this trial is testingLaboratory Treated T Cells in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, or Acute Lymphoblastic LeukemiaWho this might be right forCD19-Positive Neoplastic Cells PresentRecurrent Adult Acute Lymphoblastic LeukemiaRecurrent Chronic Lymphocytic Leukemia+10 more Fred Hutchinson Cancer Center 204